Zelira Therapeutics Limited (ZLD.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 04:10PM AEDT
| Previous close | 0.0370 |
| Open | 0.0370 |
| Bid | 0.0340 x 14831600 |
| Ask | 0.0370 x 5161300 |
| Day's range | 0.0340 - 0.0370 |
| 52-week range | 0.0340 - 0.1400 |
| Volume | |
| Avg. volume | 1,515,159 |
| Market cap | 40.471M |
| Beta (5Y monthly) | 1.05 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0070 |
| Earnings date | 21 Feb 2022 - 25 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 0.08 |
- PR Newswire
Zelira™ Launches RAF FIVE™ Acne Treatment Products Through Its Dermatology Focused Subsidiary
Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF), a global leader in the research and development of clinically validated cannabinoid medicines, is pleased to announce the US launch of the Zelira Dermatology Business' first product line, RAF FIVE™, through its dermatology subsidiary Ilera Derm LLC ("Zelira Dermatology").
- Simply Wall St.
We Think Zelira Therapeutics (ASX:ZLD) Needs To Drive Business Growth Carefully
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Simply Wall St.
A Quick Analysis On Zelira Therapeutics' (ASX:ZLD) CEO Compensation
Richard Hopkins has been the CEO of Zelira Therapeutics Limited ( ASX:ZLD ) since 2018, and this article will examine...
© 2021 Yahoo. All rights reserved.
